CORTIVAZOL

Possibly Marketed Outside US

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C32H38N2O5
Molecular Weight	530.6545
Optical Activity	UNSPECIFIED
Defined Stereocenters	8 / 8
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

C[C@@H]1C[C@H]2[C@@H]3C=C(C)C4=CC5=C(C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O)C=NN5C6=CC=CC=C6

InChI

InChIKey=RKHQGWMMUURILY-UHRZLXHJSA-N

InChI=1S/C32H38N2O5/c1-18-11-23-25-12-19(2)32(38,28(37)17-39-20(3)35)31(25,5)15-27(36)29(23)30(4)14-21-16-33-34(26(21)13-24(18)30)22-9-7-6-8-10-22/h6-11,13,16,19,23,25,27,29,36,38H,12,14-15,17H2,1-5H3/t19-,23+,25+,27+,29-,30+,31+,32+/m1/s1

HIDE SMILES / InChI

Molecular Formula	C32H38N2O5
Molecular Weight	530.6545
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	8 / 8
E/Z Centers	0
Optical Activity	UNSPECIFIED

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2205477 | https://www.ncbi.nlm.nih.gov/pubmed/16158972 | https://www.has-sante.fr/portail/upload/docs/application/pdf/2015-10/altim_version_anglaise_ct13633_def.pdf | https://www.ncbi.nlm.nih.gov/pubmed/1239292

The phenylpyrazosteroid cortivazol is a selective agonist ligand for the glucocorticoid receptor (GR), a steroid receptor member of the nuclear receptor superfamily of transcription factors. Cortivazol is an apoptotic, anti-inflammatory and immunosuppressive agent that has been used in the treatment of diskogenic radiculopathy, back pain, osteoarthritis and acute childhood lymphoblastic leukemia. Cortivazol has potent antileukemic activity in childhood ALL. Its activity is related to cell cycle arrest and induction of apoptosis. Cortivazol (Altim) is indicated in rheumatological diseases: - In intra-articular injection: inflammatory arthritis, advanced osteoarthritis. - In periarticular injection: tendinitis, bursitis. - In injection of soft tissue: talalgia, carpal tunnel syndrome, Dupuytren’s contracture. - In epidural injection: radiculalgia

CNS Activity

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Glucocorticoid receptor 173 Target ID: CHEMBL2034 Sources: https://www.ncbi.nlm.nih.gov/pubmed/17606285 \| https://www.ncbi.nlm.nih.gov/pubmed/4029081 \| https://www.ncbi.nlm.nih.gov/pubmed/2702665 \| https://www.ncbi.nlm.nih.gov/pubmed/2880860	Agonist 2752

Conditions

Condition	Modality	Targets	Highest Phase	Product
Rheumatoid arthritis 320 Sources: https://www.has-sante.fr/portail/upload/docs/application/pdf/2015-10/altim_version_anglaise_ct13633_def.pdf	Primary		Approved 8583	ALTIM Approved Use This product is indicated in rheumatological diseases: - In intra-articular injection: inflammatory arthritis, advanced osteoarthritis. - In periarticular injection: tendinitis, bursitis. - In injection of soft tissue: talalgia, carpal tunnel syndrome, Dupuytren’s contracture. - In epidural injection: radiculalgia
Musculoskeletal and joint disorders 3 Sources: http://en.pharmacodia.com/web/drug/1_11814.html https://www.drugs.com/international/altim.html https://www.vidal.fr/actualites/20916/altim_cortivazol_arret_de_production_et_d_approvisionnement_pour_une_duree_indeterminee/	Primary		Approved 8583	ALTIM Approved Use This product is indicated in rheumatological diseases: - In intra-articular injection: inflammatory arthritis, advanced osteoarthritis. - In periarticular injection: tendinitis, bursitis. - In injection of soft tissue: talalgia, carpal tunnel syndrome, Dupuytren’s contracture. - In epidural injection: radiculalgia

PubMed

Title	Date	PubMed
Injection therapy and denervation procedures for chronic low-back pain: a systematic review.	2010-09	20424870
Four cases of coccygeal disk calcification after cortivazol injection.	2009-12	19945326
Ligand-based gene expression profiling reveals novel roles of glucocorticoid receptor in cardiac metabolism.	2009-06	19293335
Effectiveness of radiation synovectomy with samarium-153 particulate hydroxyapatite in rheumatoid arthritis patients with knee synovitis: a controlled randomized double-blind trial.	2009	20037706
[The contribution of capsular distension to the treatment of primary adhesive capsulitis of the shoulder: a comparative study versus rehabilitation].	2008-12	18926581
Circumvention of glucocorticoid resistance in childhood leukemia.	2008-09	18395253
[Evaluation of the efficacy of CT-guided epidural and transforaminal steroid injections in patients with diskogenic radiculopathy].	2008-06	18641564
Gene expression profiling of leukemic cells and primary thymocytes predicts a signature for apoptotic sensitivity to glucocorticoids.	2007-11-28	18045478
Systemic effects of epidural and intra-articular glucocorticoid injections in diabetic and non-diabetic patients.	2007-10	17919959
Comparison of two structurally diverse glucocorticoid receptor agonists: cortivazol selectively regulates a distinct set of genes separate from dexamethasone in CEM cells.	2007-09	17606285
High risk of adrenal insufficiency after a single articular steroid injection in athletes.	2007-07	17596769
Benchmarking natural-language parsers for biological applications using dependency graphs.	2007-01-25	17254351
Intraarticular glucocorticoid injections in rapidly destructive hip osteoarthritis.	2006-01	16256393
Cytotoxicity of cortivazol in childhood acute lymphoblastic leukemia.	2005-09-15	16158972
The distinct agonistic properties of the phenylpyrazolosteroid cortivazol reveal interdomain communication within the glucocorticoid receptor.	2005-05	15677712
Tachon's syndrome (suracute back and/or thoracic pain following local injections of corticosteroids). A report of 318 French cases.	2005-01	15681251
Better results with rhenium-186 radiosynoviorthesis than with cortivazol in rheumatoid arthritis (RA): a two-year follow-up randomized controlled multicentre study.	2004-10-16	15485015
Synthesis of halogen-substituted pyridyl and pyrimidyl derivatives of [3,2-c]pyrazolo corticosteroids: strategies for the development of glucocorticoid receptor mediated imaging agents.	2002-11-21	12431067
Distinct interaction of cortivazol with the ligand binding domain confers glucocorticoid receptor specificity: cortivazol is a specific ligand for the glucocorticoid receptor.	2002-02-15	11741935
[Superficial injections of anti-inflammatory drugs and severe infectious complications].	2001-06-14	11402940

Patents

Sample Use Guides

In Vivo Use Guide

300 ugrams of cortivazol is equivalent in anti-inflammatory activity to about 5 mg of prednisolone. It is given in the treatment of musculoskeletal and joint disorders by intra-articular, periarticular, or epidural injection in doses of about 1.25 to 3.75 mg, usually at intervals of 1 to 3 weeks.

Route of Administration: Other

In Vitro Use Guide

Incubation of ICR 27 cells with cortivazol caused 50% growth inhibition and 50% maximal induction of glutamine synthetase activity at concentrations of 20 and 35 nM, respectively.

Substance Class	Chemical Created by `admin` on `Mon Mar 31 17:52:25 GMT 2025` Edited by `admin` on `Mon Mar 31 17:52:25 GMT 2025`
Record UNII	YM183K0H63
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

NSC-80998

Preferred Name

English

CORTIVAZOL

Official Name

English

CORTIVAZOL [MART.]

Common Name

English

CORTIVAZOL [MI]

Common Name

English

CORTIVAZOL [USAN]

Common Name

English

2'H-PREGNA-2,4,6-TRIENO(3,2-C)PYRAZOL-20-ONE, 21-(ACETYLOXY)-11,17-DIHYDROXY-6,16-DIMETHYL-2'-PHENYL-, (11.BETA.,16.ALPHA.)-

Common Name

English

11.BETA.,17,21-TRIHYDROXY-6,16.ALPHA.-DIMETHYL-2'-PHENYL-2'H-PREGNA-2,4,6-TRIENO(3,2-C)PYRAZOL-20-ONE 21-ACETATE

Common Name

English

cortivazol [INN]

Common Name

English

Cortivazol [WHO-DD]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C521